Why Aduhelm, a new Alzheimer's treatment, isn't reaching many patients

Why Aduhelm, a new Alzheimer's treatment, isn...

‏التالي

The red flags that may be hiding in your poop

When’s the last time you looked at your poop? Dr. Trisha Pasricha says you should look every time because it could save your life. A change in bowel habits is the number one indicator someone might have colon cancer, a disease on the rise in people under 50 in the United States. ...  عرض المزيد

Shooting stars are just pea-sized rocks... and other space wonders

Ahead of the peak of the Perseid meteor shower, we're re-airing our first episode with host Regina G. Barber. In it, Regina and planetary scientist Melissa Rice explore all things shooting stars. They talk about the different types, where they come from and what they actually are ...  عرض المزيد

‏حلقات موصى بها

'Some Hope Is Better Than Having No Hope'
The Daily

When the F.D.A. approved the drug Aduhelm, the first Alzheimer’s treatment to receive the agency’s endorsement in almost two decades, it gave hope to many.

But the decision was contentious; some experts say there’s not enough evidence that the treatment can address cogni ...

  عرض المزيد

Controversial new Alzheimer's drug in the spotlight
Business Daily

After decades without progress, this June a new treatment was approved by the US Food and Drugs Administration - Biogen's Aduhelm. Ivana Davidovic looks into why this process has been so controversial that is now under investigation by a federal watchdog.Aaron Kesselheim, a Harva ...  عرض المزيد

What difference could new Alzheimer’s disease drugs make?
Inside Health

Until recently, breakthroughs in treating Alzheimer’s disease were non-existent. But two new drugs have shown promise in moderately slowing memory and thinking problems for people with early-stage disease. While welcoming the idea of a ‘new era’ for treating Alzheimer’s disease, ...  عرض المزيد

Audio long read: Conquering Alzheimer’s — a look at the therapies of the future
Nature Podcast

Last year, researchers announced that the Alzheimer’s drug lecanemab lowered the amount of amyloid protein plaques associated with the disease in the brains of participants in a clinical trial, and slowed their cognitive decline.Now, researchers are looking to drug combinations, ...  عرض المزيد